- The opioid industry is an ~$50 billion annual business, but opioids are very harmful to the body and extremely addictive.
- CARA has a drug that is finishing its trials and expectation is that an NDA will be filed shortly, paving way for New Drug status and the ability to distribute.
- Korsuva is non-addictive and does away with all of the side-effects of opioids and may replace entirely the industry standard.
- $150 million distribution deal has just been inked - the company is ready to go live.
For further details see:
Cara Therapeutics Inks A Potential Blockbuster On Its Hands